The European Commission Innovation Radar identifies Aurora Medical Ltd as Key Innovator.
The Apricot consortium is happy to share that the European Commission Innovation Radar has identified the Apricot partner, Aurora Medical Limited as a Key Innovator within the Apricot project for the innovation: Implant for bone Conserving Osteoarthritis Treatment.
Details of this innovation, and how it was categorised by the analysis of the Innovation Radar, are as follows:
- Innovation Title: Implant for bone Conserving Osteoarthritis Treatment
- Market Maturity of the Innovation: Market Ready (more details on this categorisation are provided here)
- Market Creation Potential of the innovation: High (more details on this categorisation are provided here)
The Innovation Radar platform builds on the information and data gathered by independent experts involved in reviewing ongoing research and innovation projects funded by the European Commission. These experts also provide an independent view regarding the innovations in the projects and their market potential.
“We are delighted to have received this recognition from the European Commission Innovation Radar, this has reinforced our determination to transform the research results of the ground-breaking innovation to achieve maximum impact.”, says Andrew Taylor, Managing Director of Aurora Medical Ltd.